Studies have shown that SCFAs produced by Firmicutes can inhibit pathogen growth, suppress pro-inflammatory factors (like tnf-α and il-6) expressions, enhance intestinal epithelial cells’ tight junctions, stabilize the intestinal environment, and alleviate inflammatory bowel diseases [29]. The gene discussed is IL6; the disease is inflammatory bowel disease.